We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

The number of people prescribed GLP-1 drugs for weight management has skyrocketed over the past five years, according to new ...

Along with those practicalities come emotional adjustments, like the mental long division of experiencing fatphobia from a ...

So-called GLP-1 supplements, named to echo the class of glucagon-like peptide-1 agonist drugs that includes Wegovy and Zepbound, are likely to be ineffective for weight loss. “If you can buy it ...

A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could have “an antidepressant effect,” suggesting that these drugs could ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a group of drugs used to treat type 2 diabetes and sometimes obesity. GLP-1 RAs are very effective at lowering blood sugar levels.

The author supplements GLP-1 medication with vitamins and gummies to combat side effects and support overall health. Supplements mentioned include fiber, digestive enzymes, vitamins D and B12 ...

But shedding pounds and keeping them off requires more than medicine. One of the latest GLP-1 advancements is Eli Lilly's new oral obesity drug, Orforglipron, which during testing helped reduce weight ...

The work is also published in the journal Psychoneuroendocrinology. "Our findings suggest that GLP-1RAs might be just as safe and effective in adults with mental illness as they are in mentally ...

Amgen isn't a big player in the GLP-1 drug market, but that could change in the not-too-distant future. MariTide only needs to be taken once a month, and it's helped people lose up to 20% of their ...